NHS Savings and Improved Quality of Life: The Pill Switch for Young Patients
A pioneering project at Great Ormond Street Hospital (GOSH) is demonstrating how a simple switch from liquid to tablet medication can deliver significant cost savings to the NHS – potentially up to £40,000 per patient annually for certain drugs – while dramatically improving the quality of life for young patients.
The Hyperinsulinism Breakthrough
The GOSH endocrinology team focused initially on children with congenital hyperinsulinism, a rare condition affecting one in 30,000-40,000 children, characterized by excessive insulin production. The team successfully transitioned 19 patients, all aged seven or older, from liquid diazoxide to the tablet form, maintaining stable blood glucose levels throughout the process.
The benefits extended far beyond financial savings. Patients reported improved taste, greater convenience (liquid diazoxide requires glass bottles and syringes), better control of their condition, and increased independence. The cost difference is substantial: tablets cost £1.15 per 50mg dose, compared to £15.50 for the liquid equivalent.
A Multidisciplinary Approach to Patient Support
The success of the project hinged on a multidisciplinary approach. GOSH’s play team and psychologists worked closely with patients, providing learning materials and support for those who initially struggled with swallowing tablets. This highlights the importance of addressing the psychological and emotional aspects of medication adherence in young people.
Beyond Cost Savings: Prioritizing Patient Experience
Clinical Nurse Specialist Kate Morgan, who led the project, emphasized that the quality-of-life improvements were unexpected but profound. “Children are so much more than their diagnoses,” she stated. “We see very important we do all we can to make simple, positive changes that impact everyone for the better.”
The Future of Medication Formulation at GOSH
The GOSH team is now focused on expanding this approach to younger patients and investigating other medications suitable for formulation switches. This initiative aligns with GOSH’s broader Green Plan, which prioritizes sustainability and efficiency within the hospital.
Expanding the Framework: Clean Air and Beyond
GOSH’s commitment to sustainability extends beyond medication optimization. The hospital pioneered the Clean Air Hospital Framework, developed in collaboration with Global Action Plan, demonstrating a holistic approach to environmental health within healthcare settings. This framework is now being adopted by other hospitals, including University Hospitals Plymouth NHS Trust, aiming for a 70% score by 2028.
The Rise of Patient-Centric Pharmaceutical Design
The GOSH project signals a broader trend towards patient-centric pharmaceutical design. Historically, medication development has focused primarily on efficacy and safety. However, there’s a growing recognition that factors like taste, ease of administration, and convenience significantly impact adherence and overall treatment outcomes.
This shift is driven by several factors:
- Increased Patient Empowerment: Patients are increasingly involved in their healthcare decisions and expect their preferences to be considered.
- Technological Advancements: New drug delivery systems, such as orally disintegrating tablets and flavored medications, are becoming more readily available.
- Focus on Adherence: Healthcare providers are recognizing the economic and clinical consequences of poor medication adherence.
Pro Tip:
When discussing medication with your doctor, don’t hesitate to voice your preferences regarding formulation. A comfortable and convenient medication regimen is more likely to be followed consistently.
FAQ
Q: What is congenital hyperinsulinism?
A: It’s a rare condition where the body produces too much insulin, leading to low blood sugar levels.
Q: How much money could the NHS save from these medication switches?
A: Potentially up to £40,000 per patient per year for some drugs, like diazoxide.
Q: Is this approach suitable for all children?
A: The project initially focused on children aged seven and over, but the team is now exploring options for younger patients.
Q: What is the Clean Air Hospital Framework?
A: It’s a tool developed by GOSH and Global Action Plan to help hospitals improve air quality and create healthier environments.
Did you know? GOSH was the first London hospital to declare a Climate and Health Emergency in 2021, setting ambitious Net Zero emissions targets for 2030 and 2040.
Want to learn more about GOSH’s sustainability initiatives? Explore the GOSH Green Plan here.
